AXSOME THERAPEUTICS
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where current treatment options are limited or inadequate. Axsome has a balanced portfolio of clinical development stage as well as research stage products. Axsome Therapeutics aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. While the focus of the company is on developing its internally derived product candidates, Axsome also evaluates potential in-licensing opportunities to supplement its current portfolio.
AXSOME THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.axsome.com
Total Employee:
251+
Status:
Active
Contact:
+1 (212) 203-5072
Total Funding:
431.99 M USD
Technology used in webpage:
HSTS IPv6 CrUX Top 50m Common Name Invalid Microsoft CloudFront Amazon Route 53 DigiCert SSL Akamai Hosted Visual Studio
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Advisor
2021-06-01
Current Employees Featured
Herriot Tabuteau Chief Executive Officer @ Axsome Therapeutics
Chief Executive Officer
2012-01-01
Robert Niecestro VP, Head of Regulatory Affairs @ Axsome Therapeutics
VP, Head of Regulatory Affairs
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-28 | SUNOSI | SUNOSI acquired by Axsome Therapeutics | 53 M USD |
Official Site Inspections
http://www.axsome.com Semrush global rank: 1.98 M Semrush visits lastest month: 10.63 K
- Host name: 199.189.226.117
- IP address: 199.189.226.117
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Axsome Therapeutics"
About Axsome - Axsome Therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms …See details»
Axsome Therapeutics - Crunchbase Company Profile
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By …See details»
Management Team - Axsome Therapeutics
Prior to joining Axsome, he was Director of Corporate Development at Stemline Therapeutics, Inc., where he played a critical role in advancing the company from a 3-person team in 2010 to …See details»
A Brief History of Axsome Therapeutics – …
Oct 2, 2024 Furthermore, Axsome Therapeutics is dedicated to fostering a culture of innovation and excellence within the organization. The company places a strong emphasis on recruiting …See details»
Axsome Therapeutics Inc: Overview - GlobalData
Axsome Therapeutics Inc (Axsome Therapeutics ) is a biopharmaceutical company that focuses on developing novel therapies for central nervous system conditions. The company's products …See details»
Axsome Therapeutics Inc. - AnnualReports.com
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders for which there are limited treatment options. For the many people facing …See details»
Axsome Therapeutics, Inc.
6 days ago Late-breaking oral presentation of results from the positive pivotal ACCORD-2 Phase 3 trial of AXS-05 in Alzheimer’s disease agitation Presentation featuring network meta-analysis …See details»
Axsome Therapeutics, Inc. Management Team | Org Chart
Axsome Therapeutics, Inc. employs 700 employees. The Axsome Therapeutics, Inc. management team includes Herriot Tabuteau (Chief Executive Officer), Hunter Murdock (General Counsel), …See details»
Axsome Therapeutics, Inc. (AXSM): history, ownership, mission, …
Ever wonder how Axsome Therapeutics, Inc. managed to project total revenues between $345 million and $365 million for 2024, marking significant growth in the challenging …See details»
Axsome Therapeutics Enters $570 Million Term Loan and …
1 day ago Axsome Therapeutics, Inc. Previous term loan facility retired. NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a …See details»
Current Career Opportunities - Axsome Therapeutics
View a list of current career opportunities at Axsome Therapeutics and submit an application.See details»
Axsome Therapeutics - American Association for Geriatric Psychiatry
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of …See details»
Axsome Therapeutics - Funding, Financials, Valuation & Investors
Axsome Therapeutics is registered under the ticker NASDAQ:AXSM . Their stock opened with $9.00 in its Nov 20, 2015 IPO. Axsome Therapeutics is funded by Blackstone Group. Axsome …See details»
Axsome Therapeutics - Contacts, Employees, Board Members
Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders. ... Experience the new Crunchbase, …See details»
Working at Axsome Therapeutics - Zippia
Mar 14, 2024 Zippia gives an in-depth look into the details of Axsome Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about …See details»
Axsome Therapeutics Enters $570 Million Term Loan and
1 day ago NEW YORK – May 13, 2025 – Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system …See details»
Axsome Therapeutics - Leadership Team - The Org
The Leadership Team at Axsome Therapeutics is responsible for setting the strategic direction and vision of the company, overseeing the development and commercialization of innovative …See details»
Axsome Therapeutics, Inc. | LinkedIn
Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of ...See details»
Axsome Therapeutics Reports First Quarter 2025 Financial
May 5, 2025 Axsome will host a conference call and webcast today at 8:00 a.m. Eastern Time to discuss its first quarter 2025 financial results and provide a business update. To participate in …See details»
Axsome Therapeutics Provides Update on the New Drug
Aug 23, 2021 Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options.See details»